201 related articles for article (PubMed ID: 3100649)
1. Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase.
Walker EJ; Tymms KE; Webb J; Jeffrey PD
J Immunol Methods; 1987 Feb; 96(2):149-56. PubMed ID: 3100649
[TBL] [Abstract][Full Text] [Related]
2. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity.
Mathews MB; Bernstein RM
Nature; 1983 Jul 14-20; 304(5922):177-9. PubMed ID: 6866113
[TBL] [Abstract][Full Text] [Related]
3. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity.
Targoff IN; Reichlin M
J Immunol; 1987 May; 138(9):2874-82. PubMed ID: 3553328
[TBL] [Abstract][Full Text] [Related]
4. Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-1 autoantibody.
Yang DC; Dang CV; Arnett FC
Biochem Biophys Res Commun; 1984 Apr; 120(1):15-21. PubMed ID: 6712685
[TBL] [Abstract][Full Text] [Related]
5. An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum.
Biswas T; Miller FW; Takagaki Y; Plotz PH
J Immunol Methods; 1987 Apr; 98(2):243-8. PubMed ID: 3494784
[TBL] [Abstract][Full Text] [Related]
6. Purification of mammalian histidyl-tRNA synthetase and its interaction with myositis-specific anti-Jo-1 antibodies.
Fahoum SK; Yang DC
Biochemistry; 1987 Sep; 26(18):5871-7. PubMed ID: 3499936
[TBL] [Abstract][Full Text] [Related]
7. Histidyl-tRNA synthetase, the myositis Jo-1 antigen, is cytoplasmic and unassociated with the cytoskeletal framework.
Dang CV; LaDuca FM; Bell WR
Exp Cell Res; 1986 May; 164(1):261-6. PubMed ID: 3956597
[TBL] [Abstract][Full Text] [Related]
8. Antibody to threonyl-transfer RNA synthetase in myositis sera.
Targoff IN; Arnett FC; Reichlin M
Arthritis Rheum; 1988 Apr; 31(4):515-24. PubMed ID: 3128989
[TBL] [Abstract][Full Text] [Related]
9. Purification of bovine liver histidyl-tRNA synthetase, the Jo-1 antigen of polymyositis: size of the whole enzyme and its characteristic proteolytic fragments.
Walker EJ; Jeffrey PD
Biol Chem Hoppe Seyler; 1987 May; 368(5):531-7. PubMed ID: 3620106
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase).
Targoff IN; Arnett FC
Am J Med; 1990 Mar; 88(3):241-51. PubMed ID: 2178410
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of the cloned human autoantigen, histidyl-tRNA synthetase. Analysis of the myositis-associated anti-Jo-1 autoimmune response.
Ramsden DA; Chen J; Miller FW; Misener V; Bernstein RM; Siminovitch KA; Tsui FW
J Immunol; 1989 Oct; 143(7):2267-72. PubMed ID: 2476503
[TBL] [Abstract][Full Text] [Related]
12. Update on myositis-specific and myositis-associated autoantibodies.
Targoff IN
Curr Opin Rheumatol; 2000 Nov; 12(6):475-81. PubMed ID: 11092195
[TBL] [Abstract][Full Text] [Related]
13. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.
Targoff IN; Trieu EP; Miller FW
J Clin Invest; 1993 Jun; 91(6):2556-64. PubMed ID: 8514867
[TBL] [Abstract][Full Text] [Related]
14. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
[TBL] [Abstract][Full Text] [Related]
15. Intranuclear location of the myositis-specific Jo-1 antigen: hopping histidyl-tRNA synthetase?
Dang CV
Arthritis Rheum; 1985 Jul; 28(7):839-40. PubMed ID: 2409986
[No Abstract] [Full Text] [Related]
16. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis.
Goldstein R; Duvic M; Targoff IN; Reichlin M; McMenemy AM; Reveille JD; Warner NB; Pollack MS; Arnett FC
Arthritis Rheum; 1990 Aug; 33(8):1240-8. PubMed ID: 1975177
[TBL] [Abstract][Full Text] [Related]
17. Anti-Jo-1 autoantibodies and the immunopathogenesis of autoimmune myositis.
Tsui FW; Siminovitch KA
Int Rev Immunol; 1991; 7(3):225-35. PubMed ID: 1721933
[TBL] [Abstract][Full Text] [Related]
18. Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
Hervier B; Devilliers H; Benveniste O
Ann Rheum Dis; 2013 Jul; 72(7):e18. PubMed ID: 23644669
[No Abstract] [Full Text] [Related]
19. Secreted histidyl-tRNA synthetase splice variants elaborate major epitopes for autoantibodies in inflammatory myositis.
Zhou JJ; Wang F; Xu Z; Lo WS; Lau CF; Chiang KP; Nangle LA; Ashlock MA; Mendlein JD; Yang XL; Zhang M; Schimmel P
J Biol Chem; 2014 Jul; 289(28):19269-75. PubMed ID: 24898250
[TBL] [Abstract][Full Text] [Related]
20. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.
Yamasaki Y; Yamada H; Nozaki T; Akaogi J; Nichols C; Lyons R; Loy AC; Chan EK; Reeves WH; Satoh M
Arthritis Rheum; 2006 Jun; 54(6):2004-9. PubMed ID: 16732549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
